A new study found that at least 70 genetic mutations are involved in the formation of colon cancer, significantly more than was previously thought, according to a news release by UT Southwestern ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene - a gene that can cause cancer - that may play an important role in colon cancer. Researchers also showed how this ...

Scientists in Glasgow are launching a new Cancer Research UK-funded project to find a way to stop bowel cancer cells ...

CLEVELAND, Ohio — The benefits of getting regular exercise, combining two cancer drugs with chemotherapy, and using AI to ...

A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly all human colorectal cancers simply accompany the disease, or does it trigger ...

Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...

Researchers from Japan report that they have characterized gene mutations in colorectal cancer (CRC) tumors with high tumor mutation burden that lack mutations in the major oncogenes. Their findings ...

In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain immune cells in humans are less effective at fighting solid tumors compared to ...